Author(s): Parsons XH
Undeniably, heart transplantion is an effective treatment option for patients with end stage heart failure. The ten-year survival after receiving a heart in adults is over 60% . However, heart transplantation suffers from the lack of available donors and patients must wait long periods to receive a heart, often dying before a heart is made available. For this reason, appropriate management of patients on the waiting list is a difficult and complex clinical issue. Currently, there are no curative therapies for patients with heart failure except heart transplantation.